nodes	percent_of_prediction	percent_of_DWPC	metapath
Sucralfate—ALB—Crohn's disease	0.524	1	CbGaD
Sucralfate—FGG—gall bladder—Crohn's disease	0.0257	0.152	CbGeAlD
Sucralfate—FGB—gall bladder—Crohn's disease	0.0199	0.117	CbGeAlD
Sucralfate—FGA—gall bladder—Crohn's disease	0.017	0.1	CbGeAlD
Sucralfate—PGA5—digestive system—Crohn's disease	0.0115	0.0678	CbGeAlD
Sucralfate—EGF—mouth—Crohn's disease	0.011	0.0651	CbGeAlD
Sucralfate—FGB—lymphoid tissue—Crohn's disease	0.00791	0.0467	CbGeAlD
Sucralfate—FGB—digestive system—Crohn's disease	0.00782	0.0461	CbGeAlD
Sucralfate—FGA—lymphoid tissue—Crohn's disease	0.00677	0.0399	CbGeAlD
Sucralfate—FGA—digestive system—Crohn's disease	0.00669	0.0395	CbGeAlD
Sucralfate—EGF—epithelium—Crohn's disease	0.00642	0.0379	CbGeAlD
Sucralfate—EGF—smooth muscle tissue—Crohn's disease	0.00619	0.0365	CbGeAlD
Sucralfate—EGF—skin of body—Crohn's disease	0.00611	0.036	CbGeAlD
Sucralfate—FGG—lymph node—Crohn's disease	0.00578	0.0341	CbGeAlD
Sucralfate—FGF2—smooth muscle tissue—Crohn's disease	0.00546	0.0322	CbGeAlD
Sucralfate—EGF—lymphoid tissue—Crohn's disease	0.00495	0.0292	CbGeAlD
Sucralfate—FGF2—mammalian vulva—Crohn's disease	0.00491	0.029	CbGeAlD
Sucralfate—EGF—digestive system—Crohn's disease	0.00489	0.0288	CbGeAlD
Sucralfate—ALB—gall bladder—Crohn's disease	0.00429	0.0253	CbGeAlD
Sucralfate—EGF—lymph node—Crohn's disease	0.00279	0.0165	CbGeAlD
Sucralfate—FGF2—lymph node—Crohn's disease	0.00246	0.0145	CbGeAlD
Sucralfate—ALB—lymph node—Crohn's disease	0.000965	0.00569	CbGeAlD
Sucralfate—FGB—Signaling Pathways—UBE2D1—Crohn's disease	0.000119	0.00039	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—RIPK2—Crohn's disease	0.000119	0.000389	CbGpPWpGaD
Sucralfate—EGF—Disease—RBX1—Crohn's disease	0.000119	0.000388	CbGpPWpGaD
Sucralfate—EGF—Disease—HSPA1B—Crohn's disease	0.000119	0.000388	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—UBE2D1—Crohn's disease	0.000118	0.000385	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—UBE2D1—Crohn's disease	0.000117	0.000382	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—UBE2D1—Crohn's disease	0.000117	0.000382	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—TLR4—Crohn's disease	0.000116	0.000379	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TAGAP—Crohn's disease	0.000116	0.000379	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—RIPK2—Crohn's disease	0.000116	0.000378	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—ICAM1—Crohn's disease	0.000116	0.000378	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—RIPK2—Crohn's disease	0.000114	0.000373	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—ITGA4—Crohn's disease	0.000114	0.000373	CbGpPWpGaD
Sucralfate—EGF—DAP12 interactions—IL6—Crohn's disease	0.000114	0.000372	CbGpPWpGaD
Sucralfate—EGF—Fc epsilon receptor (FCERI) signaling—IL6—Crohn's disease	0.000114	0.000372	CbGpPWpGaD
Sucralfate—EGF—Signaling by FGFR in disease—IL6—Crohn's disease	0.000114	0.000372	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000114	0.000371	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—RIPK2—Crohn's disease	0.000113	0.00037	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—RIPK2—Crohn's disease	0.000113	0.00037	CbGpPWpGaD
Sucralfate—EGF—Immune System—UBE2D1—Crohn's disease	0.000113	0.000369	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—IL3—Crohn's disease	0.000113	0.000369	CbGpPWpGaD
Sucralfate—EGF—Signaling by EGFR—IL6—Crohn's disease	0.000113	0.000369	CbGpPWpGaD
Sucralfate—ALB—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000113	0.000368	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—RASGRP1—Crohn's disease	0.000112	0.000366	CbGpPWpGaD
Sucralfate—EGF—Signaling by EGFR in Cancer—IL6—Crohn's disease	0.000112	0.000365	CbGpPWpGaD
Sucralfate—EGF—Signaling by PDGF—IL6—Crohn's disease	0.000111	0.000364	CbGpPWpGaD
Sucralfate—FGF2—Downstream signal transduction—STAT3—Crohn's disease	0.000111	0.000364	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—STAT3—Crohn's disease	0.000111	0.000363	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—IFNG—Crohn's disease	0.000111	0.000362	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—IL3—Crohn's disease	0.000111	0.000361	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—IL3—Crohn's disease	0.000111	0.000361	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—TAB1—Crohn's disease	0.00011	0.000359	CbGpPWpGaD
Sucralfate—EGF—Immune System—RIPK2—Crohn's disease	0.000109	0.000358	CbGpPWpGaD
Sucralfate—EGF—Immune System—ITGA4—Crohn's disease	0.000109	0.000358	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—RASGRP1—Crohn's disease	0.000109	0.000357	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—NOD2—Crohn's disease	0.000108	0.000352	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—RASGRP1—Crohn's disease	0.000108	0.000352	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—CD79A—Crohn's disease	0.000107	0.000351	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—RASGRP1—Crohn's disease	0.000107	0.000349	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—RASGRP1—Crohn's disease	0.000107	0.000349	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—ICAM1—Crohn's disease	0.000107	0.000349	CbGpPWpGaD
Sucralfate—EGF—Immune System—IL3—Crohn's disease	0.000107	0.000349	CbGpPWpGaD
Sucralfate—EGF—Disease—UBE2D1—Crohn's disease	0.000104	0.00034	CbGpPWpGaD
Sucralfate—EGF—Immune System—RASGRP1—Crohn's disease	0.000103	0.000337	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—STAT3—Crohn's disease	0.000103	0.000337	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—ALB—Crohn's disease	0.000103	0.000337	CbGpPWpGaD
Sucralfate—EGF—Immune System—CD79A—Crohn's disease	0.000103	0.000336	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—SOCS1—Crohn's disease	0.000102	0.000332	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—RSPO3—Crohn's disease	0.000101	0.000331	CbGpPWpGaD
Sucralfate—FGF2—Signaling by Insulin receptor—IL6—Crohn's disease	0.000101	0.00033	CbGpPWpGaD
Sucralfate—EGF—Immune System—TAB1—Crohn's disease	0.000101	0.00033	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—STAT3—Crohn's disease	0.000101	0.00033	CbGpPWpGaD
Sucralfate—EGF—NGF signalling via TRKA from the plasma membrane—IL6—Crohn's disease	0.000101	0.000329	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—TYK2—Crohn's disease	0.0001	0.000328	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—SMAD3—Crohn's disease	9.94e-05	0.000325	CbGpPWpGaD
Sucralfate—FGF2—Disease—GCKR—Crohn's disease	9.93e-05	0.000324	CbGpPWpGaD
Sucralfate—EGF—Immune System—NOD2—Crohn's disease	9.92e-05	0.000324	CbGpPWpGaD
Sucralfate—FGF2—Immune System—NOD1—Crohn's disease	9.92e-05	0.000324	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—SOCS1—Crohn's disease	9.89e-05	0.000323	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—IL1B—Crohn's disease	9.88e-05	0.000323	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—SOCS1—Crohn's disease	9.76e-05	0.000319	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—SOCS1—Crohn's disease	9.69e-05	0.000317	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—SOCS1—Crohn's disease	9.69e-05	0.000317	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	9.66e-05	0.000316	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—SEL1L—Crohn's disease	9.61e-05	0.000314	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—JAK2—Crohn's disease	9.59e-05	0.000313	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—JAK2—Crohn's disease	9.57e-05	0.000313	CbGpPWpGaD
Sucralfate—EGF—Immune System—SOCS1—Crohn's disease	9.35e-05	0.000306	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CCR6—Crohn's disease	9.2e-05	0.000301	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	9.18e-05	0.0003	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	9.18e-05	0.0003	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—STAT3—Crohn's disease	9.14e-05	0.000298	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—IL3—Crohn's disease	9.11e-05	0.000298	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—TYK2—Crohn's disease	9.05e-05	0.000295	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CCR6—Crohn's disease	9.01e-05	0.000294	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—RASGRP1—Crohn's disease	8.81e-05	0.000288	CbGpPWpGaD
Sucralfate—ALB—Vitamin B12 Metabolism—TNF—Crohn's disease	8.81e-05	0.000288	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—IFNG—Crohn's disease	8.8e-05	0.000287	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CCR9—Crohn's disease	8.79e-05	0.000287	CbGpPWpGaD
Sucralfate—FGF2—Disease—SLC11A1—Crohn's disease	8.77e-05	0.000287	CbGpPWpGaD
Sucralfate—FGF2—Signaling by SCF-KIT—IL6—Crohn's disease	8.64e-05	0.000282	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—JAK2—Crohn's disease	8.63e-05	0.000282	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—SMAD3—Crohn's disease	8.54e-05	0.000279	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—PTGS2—Crohn's disease	8.44e-05	0.000276	CbGpPWpGaD
Sucralfate—EGF—Immune System—IL18—Crohn's disease	8.42e-05	0.000275	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	8.4e-05	0.000274	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—SMAD3—Crohn's disease	8.37e-05	0.000273	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—SMAD3—Crohn's disease	8.37e-05	0.000273	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—RBX1—Crohn's disease	8.32e-05	0.000272	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling of activated FGFR—IL6—Crohn's disease	8.27e-05	0.00027	CbGpPWpGaD
Sucralfate—FGF2—Immune System—PTPN2—Crohn's disease	8.24e-05	0.000269	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—CD4—Crohn's disease	8.18e-05	0.000267	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—GPR65—Crohn's disease	8.17e-05	0.000267	CbGpPWpGaD
Sucralfate—FGF2—Immune System—RBX1—Crohn's disease	8.15e-05	0.000266	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB4—IL6—Crohn's disease	8.14e-05	0.000266	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—PTGER4—Crohn's disease	8.1e-05	0.000265	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—IL2RA—Crohn's disease	7.91e-05	0.000258	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—CD4—Crohn's disease	7.86e-05	0.000257	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—IL1B—Crohn's disease	7.85e-05	0.000256	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—F5—Crohn's disease	7.84e-05	0.000256	CbGpPWpGaD
Sucralfate—FGA—Disease—TYK2—Crohn's disease	7.79e-05	0.000255	CbGpPWpGaD
Sucralfate—FGF2—Downstream signal transduction—IL6—Crohn's disease	7.77e-05	0.000254	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—IL6—Crohn's disease	7.76e-05	0.000253	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—IL2RA—Crohn's disease	7.75e-05	0.000253	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—IL2RA—Crohn's disease	7.75e-05	0.000253	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR—IL6—Crohn's disease	7.74e-05	0.000253	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB2—IL6—Crohn's disease	7.7e-05	0.000251	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—CRP—Crohn's disease	7.66e-05	0.00025	CbGpPWpGaD
Sucralfate—FGF2—DAP12 signaling—IL6—Crohn's disease	7.66e-05	0.00025	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	7.53e-05	0.000246	CbGpPWpGaD
Sucralfate—FGF2—Disease—RBX1—Crohn's disease	7.52e-05	0.000246	CbGpPWpGaD
Sucralfate—FGF2—Disease—HSPA1B—Crohn's disease	7.52e-05	0.000246	CbGpPWpGaD
Sucralfate—EGF—Immune System—IL2RA—Crohn's disease	7.48e-05	0.000244	CbGpPWpGaD
Sucralfate—EGF—Disease—SMAD3—Crohn's disease	7.46e-05	0.000244	CbGpPWpGaD
Sucralfate—FGA—Disease—JAK2—Crohn's disease	7.44e-05	0.000243	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—TLR4—Crohn's disease	7.35e-05	0.00024	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—UBE2D1—Crohn's disease	7.3e-05	0.000238	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—IL6—Crohn's disease	7.21e-05	0.000235	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—IL6—Crohn's disease	7.21e-05	0.000235	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—IL6—Crohn's disease	7.21e-05	0.000235	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—TNF—Crohn's disease	7.17e-05	0.000234	CbGpPWpGaD
Sucralfate—FGF2—Immune System—UBE2D1—Crohn's disease	7.14e-05	0.000233	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR—IL6—Crohn's disease	7.14e-05	0.000233	CbGpPWpGaD
Sucralfate—ALB—Vitamin B12 Metabolism—IL6—Crohn's disease	7.11e-05	0.000232	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—IL6—Crohn's disease	7.08e-05	0.000231	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—RIPK2—Crohn's disease	7.08e-05	0.000231	CbGpPWpGaD
Sucralfate—EGF—Immune System—CRP—Crohn's disease	7.05e-05	0.00023	CbGpPWpGaD
Sucralfate—FGA—Disease—CD4—Crohn's disease	7.05e-05	0.00023	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—IL6—Crohn's disease	7.05e-05	0.00023	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	7.05e-05	0.00023	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—STAT3—Crohn's disease	7.03e-05	0.00023	CbGpPWpGaD
Sucralfate—FGA—Disease—PTGS2—Crohn's disease	7e-05	0.000229	CbGpPWpGaD
Sucralfate—FGF2—Immune System—RIPK2—Crohn's disease	6.93e-05	0.000226	CbGpPWpGaD
Sucralfate—FGF2—Immune System—ITGA4—Crohn's disease	6.93e-05	0.000226	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—IL3—Crohn's disease	6.9e-05	0.000225	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—ICAM1—Crohn's disease	6.76e-05	0.000221	CbGpPWpGaD
Sucralfate—EGF—Immune System—TLR4—Crohn's disease	6.76e-05	0.000221	CbGpPWpGaD
Sucralfate—FGF2—Immune System—IL3—Crohn's disease	6.76e-05	0.000221	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—RASGRP1—Crohn's disease	6.68e-05	0.000218	CbGpPWpGaD
Sucralfate—FGF2—Disease—UBE2D1—Crohn's disease	6.6e-05	0.000215	CbGpPWpGaD
Sucralfate—FGF2—Immune System—RASGRP1—Crohn's disease	6.53e-05	0.000213	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CD79A—Crohn's disease	6.51e-05	0.000213	CbGpPWpGaD
Sucralfate—EGF—Immune System—ICAM1—Crohn's disease	6.48e-05	0.000212	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—TYK2—Crohn's disease	6.48e-05	0.000212	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—GCKR—Crohn's disease	6.47e-05	0.000211	CbGpPWpGaD
Sucralfate—FGF2—Immune System—TAB1—Crohn's disease	6.39e-05	0.000209	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—IL2RA—Crohn's disease	6.38e-05	0.000209	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—IL6—Crohn's disease	6.38e-05	0.000208	CbGpPWpGaD
Sucralfate—FGF2—Immune System—NOD2—Crohn's disease	6.28e-05	0.000205	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—JAK2—Crohn's disease	6.18e-05	0.000202	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—SOCS1—Crohn's disease	6.05e-05	0.000198	CbGpPWpGaD
Sucralfate—FGF2—Immune System—SOCS1—Crohn's disease	5.92e-05	0.000193	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CCR6—Crohn's disease	5.82e-05	0.00019	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—IL6—Crohn's disease	5.78e-05	0.000189	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—TYK2—Crohn's disease	5.72e-05	0.000187	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	5.72e-05	0.000187	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—TNF—Crohn's disease	5.69e-05	0.000186	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—TYK2—Crohn's disease	5.57e-05	0.000182	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—JAK2—Crohn's disease	5.46e-05	0.000178	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—TYK2—Crohn's disease	5.46e-05	0.000178	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—TYK2—Crohn's disease	5.46e-05	0.000178	CbGpPWpGaD
Sucralfate—FGA—Disease—STAT3—Crohn's disease	5.46e-05	0.000178	CbGpPWpGaD
Sucralfate—FGF2—Immune System—IL18—Crohn's disease	5.33e-05	0.000174	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—JAK2—Crohn's disease	5.31e-05	0.000174	CbGpPWpGaD
Sucralfate—EGF—Immune System—TYK2—Crohn's disease	5.27e-05	0.000172	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—RBX1—Crohn's disease	5.27e-05	0.000172	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—SMAD3—Crohn's disease	5.22e-05	0.000171	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—JAK2—Crohn's disease	5.21e-05	0.00017	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—JAK2—Crohn's disease	5.21e-05	0.00017	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—CD4—Crohn's disease	5.18e-05	0.000169	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PTGER4—Crohn's disease	5.13e-05	0.000168	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PLA2G4F—Crohn's disease	5.06e-05	0.000165	CbGpPWpGaD
Sucralfate—EGF—Immune System—JAK2—Crohn's disease	5.03e-05	0.000164	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—CD4—Crohn's disease	4.97e-05	0.000162	CbGpPWpGaD
Sucralfate—EGF—Immune System—IFNG—Crohn's disease	4.93e-05	0.000161	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—IL6—Crohn's disease	4.91e-05	0.00016	CbGpPWpGaD
Sucralfate—EGF—Disease—TYK2—Crohn's disease	4.86e-05	0.000159	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CXCL8—Crohn's disease	4.85e-05	0.000158	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—IL2RA—Crohn's disease	4.83e-05	0.000158	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—ITGA4—Crohn's disease	4.82e-05	0.000157	CbGpPWpGaD
Sucralfate—EGF—Immune System—CD4—Crohn's disease	4.76e-05	0.000156	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CXCL8—Crohn's disease	4.75e-05	0.000155	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CXCL8—Crohn's disease	4.75e-05	0.000155	CbGpPWpGaD
Sucralfate—FGF2—Immune System—IL2RA—Crohn's disease	4.73e-05	0.000155	CbGpPWpGaD
Sucralfate—FGF2—Disease—SMAD3—Crohn's disease	4.72e-05	0.000154	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—IL3—Crohn's disease	4.7e-05	0.000153	CbGpPWpGaD
Sucralfate—EGF—Disease—JAK2—Crohn's disease	4.64e-05	0.000152	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—UBE2D1—Crohn's disease	4.62e-05	0.000151	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—IL6—Crohn's disease	4.6e-05	0.00015	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—RASGRP1—Crohn's disease	4.54e-05	0.000148	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—STAT3—Crohn's disease	4.54e-05	0.000148	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—RIPK2—Crohn's disease	4.48e-05	0.000146	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CRP—Crohn's disease	4.46e-05	0.000146	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—IL6—Crohn's disease	4.42e-05	0.000145	CbGpPWpGaD
Sucralfate—EGF—Immune System—IL1B—Crohn's disease	4.4e-05	0.000144	CbGpPWpGaD
Sucralfate—EGF—Disease—CD4—Crohn's disease	4.4e-05	0.000144	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—IL3—Crohn's disease	4.37e-05	0.000143	CbGpPWpGaD
Sucralfate—EGF—Disease—PTGS2—Crohn's disease	4.37e-05	0.000143	CbGpPWpGaD
Sucralfate—ALB—Metabolism—MTMR3—Crohn's disease	4.3e-05	0.000141	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	4.29e-05	0.00014	CbGpPWpGaD
Sucralfate—FGF2—Immune System—TLR4—Crohn's disease	4.28e-05	0.00014	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—RASGRP1—Crohn's disease	4.22e-05	0.000138	CbGpPWpGaD
Sucralfate—FGF2—Immune System—ICAM1—Crohn's disease	4.1e-05	0.000134	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—TNF—Crohn's disease	3.93e-05	0.000128	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—STAT3—Crohn's disease	3.9e-05	0.000127	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—SOCS1—Crohn's disease	3.83e-05	0.000125	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—STAT3—Crohn's disease	3.82e-05	0.000125	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—STAT3—Crohn's disease	3.82e-05	0.000125	CbGpPWpGaD
Sucralfate—FGA—Disease—IL6—Crohn's disease	3.81e-05	0.000125	CbGpPWpGaD
Sucralfate—EGF—Immune System—STAT3—Crohn's disease	3.69e-05	0.000121	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—TYK2—Crohn's disease	3.41e-05	0.000111	CbGpPWpGaD
Sucralfate—EGF—Disease—STAT3—Crohn's disease	3.41e-05	0.000111	CbGpPWpGaD
Sucralfate—ALB—Metabolism—FADS1—Crohn's disease	3.35e-05	0.000109	CbGpPWpGaD
Sucralfate—FGF2—Immune System—TYK2—Crohn's disease	3.33e-05	0.000109	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—SMAD3—Crohn's disease	3.3e-05	0.000108	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—IL2RA—Crohn's disease	3.29e-05	0.000108	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—JAK2—Crohn's disease	3.25e-05	0.000106	CbGpPWpGaD
Sucralfate—FGF2—Immune System—JAK2—Crohn's disease	3.18e-05	0.000104	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—IL6—Crohn's disease	3.17e-05	0.000104	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GPX4—Crohn's disease	3.14e-05	0.000103	CbGpPWpGaD
Sucralfate—FGF2—Immune System—IFNG—Crohn's disease	3.12e-05	0.000102	CbGpPWpGaD
Sucralfate—FGF2—Disease—TYK2—Crohn's disease	3.08e-05	0.000101	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—IL2RA—Crohn's disease	3.06e-05	0.0001	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GCKR—Crohn's disease	3.03e-05	9.9e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CD4—Crohn's disease	3.02e-05	9.85e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CXCL8—Crohn's disease	2.97e-05	9.69e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—JAK2—Crohn's disease	2.94e-05	9.59e-05	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—IL6—Crohn's disease	2.8e-05	9.15e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—IL1B—Crohn's disease	2.78e-05	9.1e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—CD4—Crohn's disease	2.78e-05	9.09e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—PTGS2—Crohn's disease	2.76e-05	9.03e-05	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—IL6—Crohn's disease	2.72e-05	8.9e-05	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—IL6—Crohn's disease	2.67e-05	8.72e-05	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—IL6—Crohn's disease	2.67e-05	8.72e-05	CbGpPWpGaD
Sucralfate—EGF—Immune System—IL6—Crohn's disease	2.58e-05	8.42e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—STAT3—Crohn's disease	2.39e-05	7.79e-05	CbGpPWpGaD
Sucralfate—EGF—Disease—IL6—Crohn's disease	2.38e-05	7.77e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—STAT3—Crohn's disease	2.33e-05	7.63e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—JAK2—Crohn's disease	2.21e-05	7.23e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TYK2—Crohn's disease	2.16e-05	7.04e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—STAT3—Crohn's disease	2.16e-05	7.04e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—JAK2—Crohn's disease	2.06e-05	6.72e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.89e-05	6.19e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CXCL8—Crohn's disease	1.88e-05	6.13e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—IL6—Crohn's disease	1.67e-05	5.44e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—IL6—Crohn's disease	1.63e-05	5.33e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—STAT3—Crohn's disease	1.51e-05	4.93e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—IL6—Crohn's disease	1.51e-05	4.92e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—IL6—Crohn's disease	1.05e-05	3.44e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PTGS2—Crohn's disease	8.44e-06	2.76e-05	CbGpPWpGaD
